Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic

Audio

Description

Donald Trump and his Democratic challenger, Joe Biden, clashed over issues from the pandemic to foreign policy in their final presidential election debate. Then, the FT’s Demetri Sevastopulo will explain why local races in Texas and around the US could dictate the political make-up of the country for years to come. Plus, Gilead has received the first US regulatory approval for a Covid-19 drug, and Intel reported a decline in data centre revenues and said its earnings fell by nearly a quarter from a year ago due to the pandemic.Donald Trump and Joe Biden clash over coronavirus in final debatehttps://www.ft.com/content/bef48683-9bde-4ac2-8906-797779593b22Gilead secures FDA approval for remdesivir https://www.ft.com/content/07a321de-109b-46aa-99bc-f884e0ed7703 Hosted on Acast. See acast.com/privacy for more information.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes

🗳️ Sign in to Upvote

Popular episodes get transcribed faster

FT News Briefing

This episode hasn't been transcribed yet

Other episodes from FT News Briefing

Intel looks to level up in AI race

SpaceX IPO ignites an investor frenzy

How Ukraine’s drones turned the tables

BP shakes up its leadership … again

Global birth rates are falling…phones are a big reason why

From “What Next”: How “Tax the Rich” Went Mainstream

Sign in to Audioscrape

Share this moment